Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Amgen Inc (AMGN)
Price$406.04Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B | $25.98B | $25.42B | $23.36B | $23.75B | $22.85B | $22.99B | $21.66B | $20.06B | $18.68B | $17.27B | $15.58B | $15.05B | $14.64B | $15.00B | $14.77B |
| Gross profit | $24.71B | $20.57B | $19.74B | $19.92B | $19.52B | $19.27B | $19.01B | $19.65B | $18.78B | $18.83B | $17.43B | $15.64B | $15.33B | $14.07B | $12.87B | — | — | — | — |
| Gross margin | 67.25% | 61.53% | 70.02% | 75.66% | 75.16% | 75.77% | 81.35% | 82.73% | 82.19% | 81.90% | 80.49% | 77.96% | 82.08% | 81.47% | 82.62% | — | — | — | — |
| Research & development | $7.27B | $5.96B | $4.78B | $4.43B | $4.82B | $4.21B | $4.12B | $3.74B | $3.56B | $3.84B | $4.07B | $4.30B | $4.08B | $3.38B | $3.17B | $2.89B | $2.86B | $3.03B | $3.27B |
| Operating expenses | $27.67B | $26.17B | $20.29B | $16.76B | $18.34B | $16.29B | $13.69B | $13.48B | $12.88B | $13.20B | $13.19B | $13.87B | $12.81B | $11.69B | $11.27B | $9.51B | $9.14B | $9.79B | $10.79B |
| Operating income | $9.08B | $7.26B | $7.90B | $9.57B | $7.64B | $9.14B | $9.67B | $10.26B | $9.97B | $9.79B | $8.47B | $6.19B | $5.87B | $5.58B | $4.31B | $5.54B | $5.51B | $5.21B | $3.98B |
| Operating margin | 24.71% | 21.71% | 28.01% | 36.34% | 29.40% | 35.95% | 41.41% | 43.22% | 43.65% | 42.60% | 39.10% | 30.86% | 31.41% | 32.30% | 27.67% | 36.84% | 37.60% | 34.75% | 26.94% |
| EBITDA | $14.25B | $12.85B | $11.97B | $12.98B | $11.04B | $12.74B | $11.88B | $12.21B | $11.93B | $11.90B | $10.58B | $8.28B | $7.15B | $6.67B | $5.37B | $6.56B | $6.55B | $6.29B | $5.18B |
| EBITDA margin | 38.77% | 38.45% | 42.45% | 49.32% | 42.48% | 50.11% | 50.85% | 51.41% | 52.20% | 51.76% | 48.83% | 41.28% | 38.30% | 38.60% | 34.48% | 43.59% | 44.77% | 41.90% | 35.08% |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B | $7.26B | $7.84B | $8.39B | $1.98B | $7.72B | $6.94B | $5.16B | $5.08B | $4.34B | $3.68B | $4.63B | $4.61B | $4.05B | $3.08B |
| Net profit margin | 20.98% | 12.24% | 23.83% | 24.89% | 22.68% | 28.57% | 33.57% | 35.35% | 8.66% | 33.59% | 32.03% | 25.71% | 27.21% | 25.17% | 23.64% | 30.74% | 31.45% | 27.01% | 20.84% |
| Basic EPSper basic share | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 | $12.40 | $12.96 | $12.70 | $2.71 | $10.32 | $9.15 | $6.80 | $6.75 | $5.61 | $4.07 | $4.82 | $4.53 | $3.79 | $2.76 |
| Diluted EPSper diluted share | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 | $12.88 | $12.62 | $2.69 | $10.24 | $9.06 | $6.70 | $6.64 | $5.52 | $4.04 | $4.79 | $4.51 | $3.77 | $2.74 |
Owners
Reported shareholders
9.13%of listed shares
BlackRock, Inc.49.36M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 9.13%49.36M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 6.52%35.25M shares |
STATE STREET CORP | 5.65%30.56M shares |
Capital World Investors | 5.38%29.08M shares |
Invesco Ltd. | 3.02%16.32M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.90%15.7M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.78%15.03M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.75%14.85M shares |
MORGAN STANLEY | 2.53%13.65M shares |
WELLS FARGO & COMPANY/MN | 1.34%7.24M shares |
PRIMECAP MANAGEMENT CO/CA/ | 1.25%6.76M shares |
Capital Research Global Investors | 1.16%6.27M shares |
NORTHERN TRUST CORP | 1.15%6.2M shares |
NORGES BANK | 1.04%5.63M shares |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.00%5.39M shares |
BANK OF AMERICA CORP /DE/ | 0.94%5.06M shares |
ROYAL BANK OF CANADA | 0.80%4.33M shares |
GOLDMAN SACHS GROUP INC | 0.76%4.13M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 0.73%3.96M shares |
Amundi | 0.72%3.89M shares |
Percentages use 540.6M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 4, 2026Form 4 | Grygiel Nancy A.SVP & CCO | SellCommon Stock | 1.2K | $323.73 | $400.5K | 7.0K |
| Feb 26, 2026Form 4 | Santos EstebanEVP, Operations | SellCommon Stock | 24.3K | $379.12 | $9.21M | 76.6K |
| Feb 26, 2026Form 4 | Santos EstebanEVP, Operations | SellCommon Stock | 30.5K | $379.12 | $11.56M | 76.6K |
| Feb 19, 2026Form 4 | Busch Matthew C.VP, Finance & CAO | SellCommon Stock | 1.0K | $375.79 | $375.8K | 3.4K |
| Nov 20, 2025Form 4 | Grygiel Nancy A.SVP & CCO | SellCommon Stock | 1.6K | $337.26 | $552.8K | 7.2K |